drugset
drugset / Trial / NCT00000219

Buprenorphine Dose Alteration Study - 1

NCT00000219 ↗

Phase 1 Completed University of Vermont National Institute on Drug Abuse (NIDA) · collab
Double-blindTreatment

Summary

The purpose of this study is to examine the effects in buprenorphine dose alterations in opioid dependent individuals being maintained on buprenorphine.

Timeline

Start
1991-12
Primary completion
—
Completion
2001-07

Publications

  • Background In preparation. In preparation.

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified — —

Indications

substance-related disorder